Skip to main content
Fig. 1 | BMC Urology

Fig. 1

From: Chronic prednisone, metformin, and nonsteroidal anti-inflammatory drug use and clinical outcome in a cohort of bladder cancer patients undergoing radical cystectomy in Québec, Canada

Fig. 1

Clinical outcome of patients using NSAIDs, metformin, or prednisone before radical cystectomy

Recurrence-free, disease-specific, and overall survival in patients who chronically used NSAIDs, metformin, or prednisone before radical cystectomy, as compared to a propensity-score matched cohort of never users. Hazard ratios (HR) and their respective 95% confidence intervals (95%CI) were calculated using univariable and multivariable Cox regression models. In multivariable analyses, hazard ratios were mutually adjusted for chronic preoperative statin, NSAID, metformin, and prednisone use

NSAID, nonsteroidal anti-inflammatory drugs

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us